Form 4: Amarin CFO Peter Fishman Reports Stock Transactions

Peter Fishman, CFO of Amarin, reports transactions involving ordinary shares and restricted stock units (RSUs) related to vesting and tax liabilities.

Summary

• Peter Fishman, the SVP and CFO of Amarin, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2025, 2,600 ordinary shares were acquired through the vesting of restricted stock units (RSUs) granted in 2021.
• Also on March 1, 2025, 891 shares were withheld by the issuer to cover tax liabilities related to the vesting of these RSUs at a price of $0.63.
• On April 1, 2025, 2,500 ordinary shares were acquired through the vesting of RSUs granted in 2023.
• Additionally, on April 1, 2025, 857 shares were withheld for tax liabilities related to the vesting of these RSUs at a price of $0.65.
• Following these transactions, Fishman directly owns 76,736 ordinary shares and 2,500 RSUs.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives, ensuring compliance with SEC regulations.
• The vesting schedules and RSU grants are typical components of executive compensation packages in the pharmaceutical industry, designed to incentivize performance and align executive interests with shareholder value.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation and ownership.

Key Dates

Keywords

Form 4, Amarin, Peter Fishman, CFO, RSU, Ordinary Shares, Beneficial Ownership, Stock Incentive Plan